Stocks
Alnylam Pharmaceuticals (ALNY) Debt/EBITDA US GAAP (year values) |
||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
| Debt/EBITDA | 1.31 | 1.75 | 2.03 | 0.98 | -1.07 | -1.60 | ||
| Changes by years, y/y, % | +4% | +34% | +16% | -52% | -209% | |||
Alnylam Pharmaceuticals. Debt/EBITDA
Alnylam Pharmaceuticals. Debt/EBITDA, changes, %
Alnylam Pharmaceuticals (ALNY) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| Debt/EBITDA | 1.04 | 0.93 | 2.86 | -0.79 | -1.60 | -1.60 | ||
| Changes by years, y/y, % | -48% | -46% | +128% | -165% | -255% | |||
| Changes by quarters, q/q, % | -14% | -10% | +208% | -127% | +103% | |||
